Goldline Pharmaceutical Limited has formally intimated the appointment of M/s. Kunal Dutt & Associates, Practicing Company Secretaries, as the Internal Auditor of the Company.
The appointment was approved by the Board of Directors at its meeting held on June 09, 2026, based on the recommendation of the Audit Committee. The appointment is effective from the financial year 2026-27 and onwards.
The disclosure is made pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023.
Details of the Internal Auditor:
- Name: M/s. Kunal Dutt & Associates
- Date of Appointment: 09/06/2026
- Brief Profile: The firm is a Practicing Company Secretaries firm offering specialized services in corporate law advisory, secretarial audits, compliance management, corporate governance, audit and assurance, tax and regulatory matters, transaction advisory, and consulting. The firm is committed to delivering practical, value-driven, and compliance-oriented solutions while keeping in view the regulatory and commercial environment within which its clients operate.
- Relationship with Directors/KMP: Not related to any Director/Key Managerial Personnel of the Company.
The communication was signed and submitted by Ruchi Sanket Modi, Company Secretary cum Compliance Officer of Goldline Pharmaceutical Limited, on June 09, 2026.